18F-FDG-PET/CT findings of retroperitoneal tumors: a pictorial essay

被引:0
|
作者
Kazuhiro Kitajima
Atsushi Kono
Jyunya Konishi
Yuko Suenaga
Satoru Takahashi
Kazuro Sugimura
机构
[1] Kobe University Graduate School of Medicine,Department of Radiology
来源
关键词
Retroperitoneal tumor; Benign; Malignant; F-fluorodeoxyglucose (FDG); Positron emission tomography/computed tomography (PET/CT);
D O I
暂无
中图分类号
学科分类号
摘要
A variety of different tumors can arise from any of the tissues present in the retroperitoneum, and they exhibit a wide range of pathologic types. Although computed tomography (CT) and magnetic resonance imaging (MRI) can demonstrate important characteristics of these tumors, diagnosis is often challenging for radiologists. The purpose of this pictorial essay is to review 18F-fluorodeoxyglucose positron emission tomography/CT (FDG-PET/CT) features of different kinds of benign and malignant retroperitoneal tumors in comparison with CT or MRI findings alone and to become familiar with the wide variety of imaging characteristics.
引用
收藏
页码:301 / 309
页数:8
相关论文
共 50 条
  • [31] The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors
    Duk-Seop Shin
    Oog-Jin Shon
    Dong-Sung Han
    Joon-Hyuk Choi
    Kyung-Ah Chun
    Ihn-Ho Cho
    Annals of Nuclear Medicine, 2008, 22
  • [32] The clinical efficacy of 18F-FDG-PET/CT in benign and malignant musculoskeletal tumors
    Shin, Duk-Seop
    Shon, Oog-Jin
    Han, Dong-Sung
    Choi, Joon-Hyuk
    Chun, Kyung-Ah
    Cho, Ihn-Ho
    ANNALS OF NUCLEAR MEDICINE, 2008, 22 (07) : 603 - 609
  • [33] Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review
    Dubreuil, Julien
    Salles, Gilles
    Bozzetto, Juliette
    Tordo, Jeremie
    Djaieleb, Loiec
    Berriolo-Riedinger, Alina
    Leenhardt, Julien
    Giammarile, Francesco
    Meignan, Michel
    Skanjeti, Andrea
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (07) : 563 - 576
  • [34] Diagnostic role of 18F-FDG-PET or PET/CT in salivary gland tumors: A systematic review
    Bertagna, F.
    Nicolai, P.
    Maroldi, R.
    Mattavelli, D.
    Bertoli, M.
    Giubbini, R.
    Lombardi, D.
    Treglia, G.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2015, 34 (05): : 295 - 302
  • [35] 18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT
    Samarin, Andrei
    Huellner, Martin
    Queiroz, Marcelo A.
    Stolzmann, Paul
    Burger, Irene A.
    von Schulthess, Gustav
    Veit-Haibach, Patrick
    NUCLEAR MEDICINE COMMUNICATIONS, 2015, 36 (12) : 1165 - 1173
  • [36] The role of 18F-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!
    Hung, Te-Jui
    McLean, Luke
    Mitchell, Catherine
    Pascoe, Claire
    Lawrentschuk, Nathan
    Murphy, Declan G.
    Iravani, Amir
    Singh, Dalveer
    Hofman, Michael S.
    Zidan, Lamiaa
    Akhurst, Tim
    Lewin, Jeremy
    Hicks, Rodney J.
    CANCER IMAGING, 2019, 19 (1):
  • [37] Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas
    Liu, Dao-ning
    Li, Zhong-wu
    Wang, Hai-yue
    Zhao, Min
    Zhao, Wei
    Hao, Chun-yi
    CONTRAST MEDIA & MOLECULAR IMAGING, 2018,
  • [38] Diagnosing neuroleukemiosis: Is there a role for 18F-FDG-PET/CT?
    Sabate-Llobera, A.
    Cortes-Romera, M.
    Gamundi-Grimalt, E.
    Sanchez-Fernandez, J. J.
    Rodriguez-Bel, L.
    Gamez-Cenzano, C.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (06): : 396 - 398
  • [39] 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies
    Howard, Brandon A.
    Wong, Terence Z.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2021, 59 (05) : 737 - 753
  • [40] Utility of 18F-FDG-PET/CT in lymphoblastic lymphoma
    Fox, Thomas A.
    Carpenter, Ben
    Taj, Mary
    Perisoglou, Martha
    Nicholson, Emma
    Castleton, Anna
    Elliot, Johnathon
    Uttenthal, Ben
    Wright, Callum
    Halsey, Richard
    Khwaja, Asim
    Grandage, Victoria
    Mansour, Marc R.
    Fielding, Adele K.
    Hough, Rachael
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 1010 - 1012